Description: Q&A with Neil Sprackling, President, US Life & Health, Swiss Re, on next-generation underwriting.

Description: From a session at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999. Panelists discuss the advantages and disadvantages of the different types of reinsurance used as a financing medium.

Description: The cyber insurance market looks like it’s growing—rapidly, in fact. However, there’s more to the cyber insurance market than the outward appearance of strong growth. Worldwide aggregate premium’s upward trend may even be cause for alarm. The increase in premium against a flat rate of insured exposure is a key sign that the market could turn from growth to constriction if a solution isn’t found in the near future. If the cyber insurance sector hopes to reach such lofty goals as exceeding $30 billion in global premium by 2028, it’s going to need more capital. Whether directly into the insurance sector or via support from reinsurance and retrocession, fresh capital should help insurers achieve greater market penetration, build a broader foundation for ongoing expansion, and chart a course for long-term sustainable profitable growth. The same sources capital insurers have used since the early days of the market won’t be enough, though. Thankfully, the insurance linked securities (ILS) market seems poised to help, particularly with several promising recent transactions. New sources of capital could bolster the foundation for future cyber re/insurance growth.

Description: “Getting to Woe Some” is a thought-provoking title for Rick Flaspöhler’s recent presentation to the ACLI Reinsurance Executive Round Table in March 2005. Flaspöhler presented the high-level findings of the biennial reinsurance survey, and in his words this industry has gone from “bad to worse.” The reinsurance industry now finds itself in a unique and difficult situation that will require dramatic steps to improve things going forward.

Description: The reinsurance market is experiencing unprecedented growth in both frequency and severity of catastrophic medical claims. Most experts identify specialty drugs, new gene therapies and high-intensity hospital in-patient stays as contributing factors. With Rx claims, high-cost drug protocols are creating chronic high-cost cases over multiple years. What can actuaries do to rapidly identify these cases? If identified, what techniques can be used to reduce or manage cost? Panel will include a nationally recognized consulting actuary, health plan executive and reinsurance executive.

Description: This literature guide provides a basic grounding in a wide range of reinsurance matters for a variety of products and purposes.

Description: 1993 SOA Annual Meeting, New York. This session is about how rating agencies think about reinsurance. Topics discussed: 1. How do various rating agencies view reinsurance? 2. How do new RBC standards impact rating agencies' view regarding reinsurance? 3. To what extent do ceding companies factor in rating agency concerns in their reinsurance decision making?

Description: From 2000 Valuation Actuary Symposium Panel discussion which provides an overview of the current uses of reinsurance, focusing on recent developments and issues. Panelists discussed application of reinsurance to specific products and lines of business and its use as a financial management tool in: • Term insurance • Mortality stabilization • Earnings volatility stabilization • Variable life and annuities and other investment-oriented products Generally Accepted Accounting Principles GAAP treatment of reinsurance e.g., FAS 113 and due diligence issues in selecting reinsurers and maintaining reinsurance arrangements is also discussed. Finally, panelists discussed advantages of onshore and offshore reinsurance transactions.

Description: This session at the SOA 1998 Maui I Spring Meeting features a debate over the question of whether the typical wording in a YRT reinsurance treaty allows a reinsurer to raise their rates or not.

Description: This session from the 1983 SOA Spring Meeting discusses reinsurance including the effects of TEFRA on reinsurance tax planning, a picture of the reinsurance market over the last 10 years and surplus relief.